Monday, Mar 08, 2021
Focus on the big picture

Eli Lilly's COVID-19 drug gets U.S. authorization

Reuters, 10 Feb 2021
The U.S. Food and Drug Administration authorized emergency use of Eli Lilly’s combination antibody therapy to fight COVID-19 in patients to help cut the risk of hospitalization and death.

#EliLilly #COVID19 #News #COVIDtreatment

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Related Articles